LD-2 disclosure · 1st Quarter - Report
SAGE THERAPEUTICS
Client
- Location
- Massachusetts · United States of America
Registrant
- Description
- Pharmaceutical manufacturing
- Location
- Cambridge, Massachusetts, United States of America
Lobbying activities
3 issuesHealth Issues
Maternal Mental Health - Black Maternal Health Momnibus Act of 2021, H.R. 959 and American Rescue Plan Act of 2021, H.R. 1319 (Extension of Medicaid Benefits to 12 months from 60 days post partum) Hospital Site of Care Reforms - DRG education Mental Health - pandemic related education and telehealth Medicare Part D Reform - HR.3 and the Prescription Drug Pricing Reduction Act of 2020,
LobbyistsVANESSA PROCTER
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
H.R.3 and Prescription Drug Pricing Reduction Act, specifically, language attributed to LIS reforms.
LobbyistsVANESSA PROCTER
TargetedSENATE · HOUSE OF REPRESENTATIVES
Trade (domestic/foreign)
TRIPS COVID-19 Waiver
LobbyistsVANESSA PROCTER
TargetedSENATE · HOUSE OF REPRESENTATIVES